This article was originally published on this site
iRadimed Corporation (IRMD) traded on unusually high volume on Jul. 11, as the stock gained 0.44% to close at $22.90. On the day, iRadimed Corporation saw 74,570 shares trade hands on 421 trades. Considering that the stock averages only a daily volume of 42,773 shares a day over the last month, this represents a pretty significant bump in volume over the norm.
Generally speaking, when a stock experiences a sudden spike in trading volume, it may be seen as a bullish signal for investors. An increase in volume means more market awareness for the company, potentially setting up a more meaningful move in stock price. The added volume also provides a level of support and stability for price advances.
The stock has traded between $23.10 and $8.25 over the last 52-weeks, its 50-day SMA is now $18.95, and its 200-day SMA $14.86. iRadimed Corporation has a P/B ratio of 7.13. It also has a P/E ratio of 175.4.
iRadimed Corp develops, manufactures, markets and distributes Magnetic Resonance Imaging compatible products to acute care facilities and outpatient imaging centers, both in the United States and internationally.
Headquartered in Winter Springs, FL, iRadimed Corporation has 83 employees and is currently under the leadership of CEO Roger Susi.
For a complete fundamental analysis analysis of iRadimed Corporation, check out Equities.com’s Stock Valuation Analysis report for IRMD.
Still paying commissions on stock trades? Equities.com now offers 100% commission free stock trading and flat-fee options trading for $89.95/month! Get started today by https://www.equities.com/trading
To get more information on iRadimed Corporation and to follow the company’s latest updates, you can visit the company’s profile page here: IRMD’s Profile. For more news on the financial markets and emerging growth companies, be sure to visit Equities.com’s Newsdesk. Also, don’t forget to sign-up for our daily email newsletter to ensure you don’t miss out on any of our best stories.
All data provided by QuoteMedia and was accurate as of 4:30PM ET.
DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer